Your Ad Here
PatientsVille.com> Optimark Report List> Optimark Side Effects
If You had Optimark side effect, You are not alone. Other patients reported side effects.
Do You Have Optimark Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Optimark Community

Ask patient community about Optimark related health issues.

View FDA Reports

Optimark adverse events reported to FDA.

Have You Experienced unusual Optimark symptoms? PatientsVille.com collects and analyzes Optimark side effect and adverse reports submitted by Optimark users, such as Burning joints and muscles. Cramping and inflexible|.

Summary

FDA Adverse Reports: 156. View All

Optimark FDA safety alerts: 2006 2007

Reported deaths: 33

Reported hospitalizations: 78

Optimark Dosage, Warnings, Usage.

Post Your Unusual Symptoms:

Most Reported
Recent Drug Reports

Burning joints and muscles. Cramping and inflexible

More Optimark Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Optimark, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Optimark users, Learn more about unwanted side effects & find ways to reduce them. Browse Optimark Adverse Reports reported to FDA and participate in Optimark discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Optimark. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Optimark Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

Showing 1-50 of 156  Next Page  >

7014344-0 | Amnesia, Anxiety, Atrial Flutter, Bronchitis, Depression, Dermal Cyst, Fall, Hyperhidrosis, Joint Injury
on Sep 16, 2010 Male patient from UNITED STATES , weighting 389.9 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging abdominal, nuclear magnetic resonance imaging brain, coagulopathy, blood testosterone decreased and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anxiety (What is anxiety?), atrial flutter, bronchitis (What is bronchitis?), depression (What is depression?), dermal cyst, fall (What is fall?), hyperhidrosis, joint injury. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), WARFARIN (View Warfarin Review and Warfarin Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ), AVAPRO (Unk) (View Avapro Review and Avapro Label ), FLOMAX (Unk) (View Flomax Review and Flomax Label ).

7012428-4 | Abscess Limb, Arteriovenous Fistula Site Haematoma, Arteriovenous Fistula Thrombosis, Asteatosis, Back Pain, Bronchitis, Conjunctivitis, Depression, Device Related Infection
Patient was taking Optimark (View Usage). Patient had the following side effects: abscess limb, arteriovenous fistula site haematoma, arteriovenous fistula thrombosis, asteatosis, back pain (What is back pain?), bronchitis (What is bronchitis?), conjunctivitis, depression (What is depression?), device related infection on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 279.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain, nuclear magnetic resonance imaging abdominal and. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ).

7009301-4 | Anaemia, Arrhythmia, Arthritis, Arthritis Bacterial, Back Pain, Cerebral Ischaemia, Confusional State, Deep Vein Thrombosis, Device Related Sepsis
Adverse event was reported on Sep 16, 2010 by a Male patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with nuclear magnetic resonance imaging brain, mineral supplementation, impaired gastric emptying, arthralgia, musculoskeletal pain and. Location: UNITED STATES , weighting 234.8 lb, After Optimark was administered, patient had the following side effects: anaemia, arrhythmia (What is arrhythmia?), arthritis (What is arthritis?), arthritis bacterial, back pain (What is back pain?), cerebral ischaemia, confusional state, deep vein thrombosis (What is deep vein thrombosis?), device related sepsis. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), PHOSLO (16 Tabs Daily) (View Phoslo Review and Phoslo Label ), METOPROLOL TARTRATE (50 Mg (1 Tab), Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), REGLAN (5 Mg, A.c) (View Reglan Review and Reglan Label ), OXYCODONE HCL (5 Mg, Q4h) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (1-2 Times Daily) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6960152-6 | Arteriosclerosis, Asthenia, Calciphylaxis, Encephalopathy, Hypoaesthesia, Intervertebral Disc Disorder, Lower Limb Fracture, Nephrogenic Systemic Fibrosis
on Aug 26, 2010 Male patient from GERMANY , weighting 223.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, arteriogram carotid and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, asthenia, calciphylaxis, encephalopathy, hypoaesthesia, intervertebral disc disorder, lower limb fracture, nephrogenic systemic fibrosis. Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (Unk, Unk, Single) (View Magnevist Review and Magnevist Label ), OMNISCAN (42 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk Unk, Single) (View Gadolinium Review and Gadolinium Label ), RENAGEL /01459901/ (Unk) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), NIFEREX /01214501/ (Unk) (View Niferex /01214501/ Review and Niferex /01214501/ Label ).


6954970-8 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
on Aug 20, 2010 Male patient from UNITED STATES , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Optimark (View Usage). Patient had the following side effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), OMNISCAN (Unk, Single) (View Omniscan Review and Omniscan Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6925066-6 | Acute Sinusitis, Anaemia Of Chronic Disease, Antiphospholipid Syndrome, Arthralgia, Atelectasis, Atrial Fibrillation, Balance Disorder, Basal Cell Carcinoma, Bk Virus Infection
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: acute sinusitis, anaemia of chronic disease, antiphospholipid syndrome, arthralgia, atelectasis, atrial fibrillation (What is atrial fibrillation?), balance disorder, basal cell carcinoma, bk virus infection on Aug 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 196.0 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROZAC /00724401/ (View Prozac /00724401/ Review and Prozac /00724401/ Label ), VALIUM (View Valium Review and Valium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6913364-1 | Acute Sinusitis, Antiphospholipid Syndrome, Arthralgia, Atrial Fibrillation, Basal Cell Carcinoma, Cataract, Deep Vein Thrombosis, Entropion, Face Injury
Adverse event was reported on Jul 28, 2010 by a Male patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with angiogram, nuclear magnetic resonance imaging and. Location: UNITED STATES , weighting 196.0 lb, Patient experienced the following unwanted or unexpected effects: acute sinusitis, antiphospholipid syndrome, arthralgia, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cataract (What is cataract?), deep vein thrombosis (What is deep vein thrombosis?), entropion, face injury. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROZAC /00724401/ (View Prozac /00724401/ Review and Prozac /00724401/ Label ), VALIUM (View Valium Review and Valium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6910261-2 | Bacteraemia, Basal Cell Carcinoma, Bladder Spasm, Blepharochalasis, Chronic Obstructive Pulmonary Disease, Dermal Cyst, Eyelid Ptosis, Gastrointestinal Haemorrhage, Hypophosphataemia
on Jul 27, 2010 Male patient from UNITED STATES , weighting 178.0 lb, was diagnosed with nuclear magnetic resonance imaging, prophylaxis against transplant rejection and was treated with Optimark (View Usage). Patient had the following side effects: bacteraemia, basal cell carcinoma, bladder spasm, blepharochalasis, chronic obstructive pulmonary disease, dermal cyst, eyelid ptosis, gastrointestinal haemorrhage, hypophosphataemia. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), PROHANCE (Unk) (View Prohance Review and Prohance Label ), MULTIHANCE (Unk) (View Multihance Review and Multihance Label ), SIROLIMUS (Unk) (View Sirolimus Review and Sirolimus Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6905218-1 | Lip Swelling, Off Label Use, Swollen Tongue
on Jul 29, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with angiogram cerebral, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: lip swelling, off label use, swollen tongue. Optimark dosage: 15 Ml, Single. During the same period patient was treated with VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6870591-X | Arteriosclerosis, Asthenia, Calciphylaxis, Encephalopathy, Intervertebral Disc Disorder, Lower Limb Fracture, Nephrogenic Systemic Fibrosis, Pericardial Effusion
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, asthenia, calciphylaxis, encephalopathy, intervertebral disc disorder, lower limb fracture, nephrogenic systemic fibrosis, pericardial effusion on Jul 14, 2010 from GERMANY Additional patient health information: Male patient , weighting 223.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, arteriogram carotid and. Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (Unk, Unk, Single) (View Magnevist Review and Magnevist Label ), OMNISCAN (42 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk Unk, Single) (View Gadolinium Review and Gadolinium Label ), RENAGEL /01459901/ (Unk) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), NIFEREX /01214501/ (Unk) (View Niferex /01214501/ Review and Niferex /01214501/ Label ).

6822030-2 | Abdominal Pain, Activities Of Daily Living Impaired, Anaphylactic Shock, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Cough
Adverse event was reported on Jul 01, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , weighting 174.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), activities of daily living impaired, anaphylactic shock, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), cough. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), ALPRAZOLAM (0.5 Mg,1 Tablet Hs Prn) (View Alprazolam Review and Alprazolam Label ), ZITHROMAX (500 Mg, Tri-pak) (View Zithromax Review and Zithromax Label ). Patient was hospitalized.

6819010-X | Abdominal Pain Upper, Acute Respiratory Failure, Arteriovenous Graft Site Abscess, Asthenia, Atrial Fibrillation, Diabetic Ulcer, Diarrhoea, Fluid Overload
on Jun 28, 2010 Female patient from UNITED STATES , weighting 215.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal pain upper, acute respiratory failure, arteriovenous graft site abscess, asthenia, atrial fibrillation (What is atrial fibrillation?), diabetic ulcer, diarrhoea, fluid overload. Optimark dosage: 40 Ml, Single. During the same period patient was treated with MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), NORVASC (View Norvasc Review and Norvasc Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

6819009-3 | Activities Of Daily Living Impaired, Adenoma Benign, Cardiac Failure Congestive, Cardiomyopathy, Carotid Artery Stenosis, Cholelithiasis, Cough, Dizziness, Dysarthria
on Jul 01, 2010 Male patient from UNITED STATES , weighting 261.4 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, adenoma benign, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), carotid artery stenosis, cholelithiasis, cough, dizziness (What is dizziness?), dysarthria. Optimark dosage: 20 Ml, Single. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), LOTENSIN HCT (Unk) (View Lotensin Hct Review and Lotensin Hct Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6782966-8 | Anaemia, Arrhythmia, Arthritis, Arthritis Bacterial, Back Pain, Cerebral Ischaemia, Confusional State, Deep Vein Thrombosis, Device Related Sepsis
Patient was taking Optimark (View Usage). Patient had the following side effects: anaemia, arrhythmia (What is arrhythmia?), arthritis (What is arthritis?), arthritis bacterial, back pain (What is back pain?), cerebral ischaemia, confusional state, deep vein thrombosis (What is deep vein thrombosis?), device related sepsis on Jun 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 234.8 lb, was diagnosed with nuclear magnetic resonance imaging brain, mineral supplementation, impaired gastric emptying, arthralgia, musculoskeletal pain and. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), PHOSLO (16 Tabs Daily) (View Phoslo Review and Phoslo Label ), METOPROLOL TARTRATE (50 Mg (1 Tab), Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), REGLAN (5 Mg, A.c) (View Reglan Review and Reglan Label ), OXYCODONE (5 Mg, Q4h) (View Oxycodone Review and Oxycodone Label ), OXYCONTIN (1-2 Times Daily) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6771084-0 | Abdominal Pain Upper, Angina Unstable, Aortic Valve Incompetence, Cardiac Arrest, Cardiac Failure Congestive, Coagulopathy, Diverticulum, Epistaxis, Fall
Adverse event was reported on Jun 10, 2010 by a Female patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with angiogram and. Location: UNITED STATES , weighting 135.0 lb, After Optimark was administered, patient had the following side effects: abdominal pain upper, angina unstable, aortic valve incompetence, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, coagulopathy, diverticulum, epistaxis, fall (What is fall?). During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), OMNISCAN (100 Ml, Single) (View Omniscan Review and Omniscan Label ), VERAPAMIL (240 Mg, Qd) (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6766376-5 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
on Jun 04, 2010 Male patient from UNITED STATES , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), OMNISCAN (Unk, Single) (View Omniscan Review and Omniscan Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6765361-7 | Anaemia, Arthritis, Arthritis Bacterial, Back Pain, Cerebral Ischaemia, Confusional State, Deep Vein Thrombosis, Device Related Sepsis, Diarrhoea
on Jun 01, 2010 Male patient from UNITED STATES , weighting 234.8 lb, was diagnosed with nuclear magnetic resonance imaging brain, mineral supplementation, impaired gastric emptying, arthralgia, musculoskeletal pain and was treated with Optimark (View Usage). Patient had the following side effects: anaemia, arthritis (What is arthritis?), arthritis bacterial, back pain (What is back pain?), cerebral ischaemia, confusional state, deep vein thrombosis (What is deep vein thrombosis?), device related sepsis, diarrhoea. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), PHOSLO (16 Tabs Daily) (View Phoslo Review and Phoslo Label ), METOPROLOL TARTRATE (50 Mg (1 Tab), Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), REGLAN (5 Mg, A.c) (View Reglan Review and Reglan Label ), OXYCODONE (5 Mg, Q4h) (View Oxycodone Review and Oxycodone Label ), OXYCONTIN (1-2 Times Daily) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6750350-9 | Abdominal Pain, Acute Pulmonary Oedema, Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Anaemia, Asthenia, Back Pain, Cardiac Failure Congestive, Cardio-respiratory Arrest
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), acute pulmonary oedema, acute respiratory distress syndrome, acute respiratory failure, anaemia, asthenia, back pain (What is back pain?), cardiac failure congestive, cardio-respiratory arrest on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 121.5 lb, was diagnosed with renal mass, renal abscess and. Optimark dosage: 20 Ml, Single. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6744951-1 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
Adverse event was reported on May 18, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging, angiogram and. Location: UNITED STATES , weighting 156.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk, Single) (View Gadolinium Review and Gadolinium Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6744944-4 | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Cervicobrachial Syndrome, Clostridium Difficile Colitis, Confusional State
on May 18, 2010 Male patient from UNITED STATES , weighting 159.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and was treated with Optimark (View Usage). Patient had the following side effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, cervicobrachial syndrome, clostridium difficile colitis, confusional state. Optimark dosage: 19 Ml, Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6741186-3 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
on May 18, 2010 Male patient from UNITED STATES , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk, Single) (View Gadolinium Review and Gadolinium Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6741182-6 | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Cervicobrachial Syndrome, Clostridium Difficile Colitis, Confusional State
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, cervicobrachial syndrome, clostridium difficile colitis, confusional state on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 159.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and. Optimark dosage: 19 Ml, Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6735350-7 | Acute Sinusitis, Atrial Fibrillation, Basal Cell Carcinoma, Cataract, Deep Vein Thrombosis, Entropion, Fall, Fatigue, Leukocytosis
Adverse event was reported on May 13, 2010 by a Male patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with angiogram, nuclear magnetic resonance imaging and. Location: UNITED STATES , weighting 196.0 lb, Patient had the following side effects: acute sinusitis, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cataract (What is cataract?), deep vein thrombosis (What is deep vein thrombosis?), entropion, fall (What is fall?), fatigue, leukocytosis. During the same period patient was treated with GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROZAC /00724401/ (View Prozac /00724401/ Review and Prozac /00724401/ Label ), VALIUM (View Valium Review and Valium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6725228-7 | Abasia, Acute Coronary Syndrome, Acute Myocardial Infarction, Alopecia, Anaemia, Arteriovenous Fistula Site Complication, Atrial Fibrillation, Basal Cell Carcinoma, Cardiac Failure Congestive
on May 07, 2010 Female patient from UNITED STATES , weighting 183.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abasia, acute coronary syndrome, acute myocardial infarction, alopecia, anaemia, arteriovenous fistula site complication, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cardiac failure congestive. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk, Single) (View Magnevist Review and Magnevist Label ). Patient was hospitalized and became disabled.

6716842-3 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
on May 03, 2010 Male patient from UNITED STATES , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6715061-4 | Blister, Cardio-respiratory Arrest, Cardiomegaly, Dysphagia, Dysphonia, Impaired Healing, Laryngeal Mass, Nephrogenic Systemic Fibrosis, Oesophageal Infection
Patient was taking Optimark (View Usage). Patient had the following side effects: blister, cardio-respiratory arrest, cardiomegaly, dysphagia, dysphonia, impaired healing, laryngeal mass, nephrogenic systemic fibrosis, oesophageal infection on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 189.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain, angiogram and. Optimark dosage: 15 Ml, Single. During the same period patient was treated with OMNISCAN (15 Ml, Single) (View Omniscan Review and Omniscan Label ), PROHANCE (Unk) (View Prohance Review and Prohance Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6709181-8 | Blister, Cardio-respiratory Arrest, Cardiomegaly, Dysphagia, Dysphonia, Impaired Healing, Laryngeal Mass, Nephrogenic Systemic Fibrosis, Oesophageal Infection
Adverse event was reported on Apr 23, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 15 Ml, Single) was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain, angiogram and. Location: UNITED STATES , weighting 189.0 lb, After Optimark was administered, patient had the following side effects: blister, cardio-respiratory arrest, cardiomegaly, dysphagia, dysphonia, impaired healing, laryngeal mass, nephrogenic systemic fibrosis, oesophageal infection. During the same period patient was treated with OMNISCAN (15 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6696115-8 | Activities Of Daily Living Impaired, Anaphylactic Shock, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Cough, Depression
on Apr 19, 2010 Male patient from UNITED STATES , weighting 174.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, anaphylactic shock, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), cough, depression (What is depression?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), ALPRAZOLAM (0.5 Mg,1 Tablet Hs Prn) (View Alprazolam Review and Alprazolam Label ), ZITHROMAX (500 Mg, Tri-pak) (View Zithromax Review and Zithromax Label ). Patient was hospitalized.

6696109-2 | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Cervicobrachial Syndrome, Clostridium Difficile Colitis, Confusional State
on Apr 19, 2010 Male patient from UNITED STATES , weighting 159.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and was treated with Optimark (View Usage). Patient had the following side effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, cervicobrachial syndrome, clostridium difficile colitis, confusional state. Optimark dosage: 19 Ml, Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6696108-0 | Arterial Occlusive Disease, Chest Pain, Convulsion, Deep Vein Thrombosis, Encephalomalacia, Erosive Duodenitis, Fluid Overload, Gait Disturbance, Haemorrhagic Stroke
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: arterial occlusive disease, chest pain (What is chest pain?), convulsion, deep vein thrombosis (What is deep vein thrombosis?), encephalomalacia, erosive duodenitis, fluid overload, gait disturbance, haemorrhagic stroke on Apr 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, arteriogram renal, vaginal infection, anxiety (What is anxiety?), hypertension, blood phosphorus increased and. Optimark dosage: 1 Ml, Single. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), DIFLUCAN (150 Mg, Qd) (View Diflucan Review and Diflucan Label ), XANAX (.25 Mg, Q12 Prn) (View Xanax Review and Xanax Label ), ATENOLOL (50 Mg, Bid) (View Atenolol Review and Atenolol Label ), RENAGEL /01459901/ (1600 Mg, Tid) (View Renagel /01459901/ Review and Renagel /01459901/ Label ).

6690705-4 | Abdominal Pain Upper, Acute Respiratory Failure, Arteriovenous Graft Site Abscess, Asthenia, Atrial Fibrillation, Diabetic Ulcer, Diarrhoea, Fluid Overload
Adverse event was reported on Apr 09, 2010 by a Female patient taking Optimark (View Usage) (Dosage: 40 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , weighting 215.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, acute respiratory failure, arteriovenous graft site abscess, asthenia, atrial fibrillation (What is atrial fibrillation?), diabetic ulcer, diarrhoea, fluid overload. During the same period patient was treated with MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), NORVASC (View Norvasc Review and Norvasc Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6689875-3 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fall
on Apr 12, 2010 Male patient from UNITED STATES , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Optimark (View Usage). Patient had the following side effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fall (What is fall?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), VISIPAQUE (Unk) (View Visipaque Review and Visipaque Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6683350-8 | Activities Of Daily Living Impaired, Adenoma Benign, Cardiac Failure Congestive, Cardiomyopathy, Carotid Artery Stenosis, Cholelithiasis, Cough, Dizziness, Dysarthria
on Apr 09, 2010 Male patient from UNITED STATES , weighting 261.4 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: activities of daily living impaired, adenoma benign, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), carotid artery stenosis, cholelithiasis, cough, dizziness (What is dizziness?), dysarthria. Optimark dosage: 20 Ml, Single. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), LOTENSIN HCT (Unk) (View Lotensin Hct Review and Lotensin Hct Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6682440-3 | Abscess, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Depression, Gastrointestinal Haemorrhage, Joint Sprain, Myocardial Infarction, Nephrogenic Systemic Fibrosis
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), cardiac failure congestive, chronic obstructive pulmonary disease, depression (What is depression?), gastrointestinal haemorrhage, joint sprain, myocardial infarction, nephrogenic systemic fibrosis on Apr 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram, nuclear magnetic resonance imaging brain and. Optimark dosage: 20 Ml (cc), Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6677754-7 | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Cervicobrachial Syndrome, Clostridium Difficile Colitis, Confusional State
Adverse event was reported on Mar 31, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 19 Ml, Single) was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and. Location: UNITED STATES , weighting 159.2 lb, Patient had the following side effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, cervicobrachial syndrome, clostridium difficile colitis, confusional state. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6668320-8 | Abdominal Pain Upper, Angina Unstable, Aortic Valve Incompetence, Cardiac Arrest, Cardiac Failure Congestive, Coagulopathy, Diverticulum, Epistaxis, Fall
on Mar 25, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with angiogram, arteriovenous fistula operation and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal pain upper, angina unstable, aortic valve incompetence, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, coagulopathy, diverticulum, epistaxis, fall (What is fall?). Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), OMNISCAN (100 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6657564-7 | Abscess, Cardiac Failure Congestive, Depression, Joint Sprain, Myocardial Infarction, Nephrogenic Systemic Fibrosis, Off Label Use, Osteomyelitis
on Mar 23, 2010 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), cardiac failure congestive, depression (What is depression?), joint sprain, myocardial infarction, nephrogenic systemic fibrosis, off label use, osteomyelitis. Optimark dosage: 20 Ml (cc), Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6654180-8 | Arteriosclerosis Coronary Artery, Ascites, Breast Mass, Bundle Branch Block Left, Cardiac Failure Congestive, Cataract, Clubbing, Congestive Cardiomyopathy, Coronary Artery Stenosis
Patient was taking Optimark (View Usage). Patient had the following side effects: arteriosclerosis coronary artery, ascites, breast mass, bundle branch block left, cardiac failure congestive, cataract (What is cataract?), clubbing, congestive cardiomyopathy, coronary artery stenosis on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 152.0 lb, was diagnosed with angiogram, venogram, hypertension, dialysis (What is dialysis?) and. Optimark dosage: Unk. During the same period patient was treated with HYDRALAZINE HCL (100 Mg (2 Tablets), Tid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), IMDUR (30 Mg, Qd) (View Imdur Review and Imdur Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ), PHOSLO (667 Mg, Tid (1 Tablet With Meals)) (View Phoslo Review and Phoslo Label ), RENAGEL /01459901/ (1600 Mg, Tid) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), PREVACID (30 Mg, Qd (1 Tablet Before Breakfast)) (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6650382-5 | Abasia, Acute Coronary Syndrome, Acute Myocardial Infarction, Alopecia, Anaemia, Anhedonia, Anxiety, Arteriovenous Fistula Site Complication, Atrial Fibrillation
Adverse event was reported on Mar 12, 2010 by a Female patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and. Location: UNITED STATES , weighting 183.0 lb, After Optimark was administered, patient had the following side effects: abasia, acute coronary syndrome, acute myocardial infarction, alopecia, anaemia, anhedonia, anxiety (What is anxiety?), arteriovenous fistula site complication, atrial fibrillation (What is atrial fibrillation?). During the same period patient was treated with MAGNEVIST (Unk, Single) (View Magnevist Review and Magnevist Label ). Patient was hospitalized and became disabled.

6650380-1 | Anaemia, Haematuria, Haemorrhage, Intestinal Perforation, Nephrogenic Systemic Fibrosis, Oedema, Pain In Extremity, Venous Stenosis
on Feb 23, 2010 Male patient from UNITED STATES , weighting 188.5 lb, was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematuria, haemorrhage, intestinal perforation, nephrogenic systemic fibrosis, oedema, pain in extremity, venous stenosis. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6648285-5 | Acute Sinusitis, Atrial Fibrillation, Basal Cell Carcinoma, Cataract, Deep Vein Thrombosis, Entropion, Fall, Fatigue, Leukocytosis
on Mar 10, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient had the following side effects: acute sinusitis, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cataract (What is cataract?), deep vein thrombosis (What is deep vein thrombosis?), entropion, fall (What is fall?), fatigue, leukocytosis. Optimark dosage: Unk. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), PROZAC /00724401/ (View Prozac /00724401/ Review and Prozac /00724401/ Label ), VALIUM (View Valium Review and Valium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NASALIDE (View Nasalide Review and Nasalide Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6645064-X | Abasia, Abdominal Discomfort, Arteriosclerosis Coronary Artery, Arthropathy, Atelectasis, Benign Prostatic Hyperplasia, Calculus Ureteric, Chest Pain, Cholelithiasis
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: abasia, abdominal discomfort, arteriosclerosis coronary artery, arthropathy, atelectasis, benign prostatic hyperplasia, calculus ureteric, chest pain (What is chest pain?), cholelithiasis on Mar 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), TYLENOL (CAPLET) (1000 Mg, Every 6 Hrs Prn) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ZOFRAN (Every 6 Hrs Prn) (View Zofran Review and Zofran Label ), DARVOCET A500 (1 Tablet Every 4 Hrs Prn) (View Darvocet A500 Review and Darvocet A500 Label ), TUMS /00108001/ (500 Mg, 1 Tablet 30 Minutes Before Meals) (View Tums /00108001/ Review and Tums /00108001/ Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6645061-4 | Abdominal Pain, Acute Pulmonary Oedema, Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Anaemia, Asthenia, Back Pain, Cardiac Failure Congestive, Cardio-respiratory Arrest
Adverse event was reported on Mar 09, 2010 by a Female patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with renal mass, renal abscess, submandibular mass, neck mass and. Location: UNITED STATES , weighting 121.5 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), acute pulmonary oedema, acute respiratory distress syndrome, acute respiratory failure, anaemia, asthenia, back pain (What is back pain?), cardiac failure congestive, cardio-respiratory arrest. During the same period patient was treated with GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

6645059-6 | Abdominal Pain Upper, Angina Unstable, Aortic Valve Incompetence, Cardiac Arrest, Cardiac Failure Congestive, Coagulopathy, Diverticulum, Epistaxis, Fall
on Mar 09, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with angiogram and was treated with Optimark (View Usage). Patient had the following side effects: abdominal pain upper, angina unstable, aortic valve incompetence, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, coagulopathy, diverticulum, epistaxis, fall (What is fall?). Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), VERAPAMIL (240 Mg, Qd) (View Verapamil Review and Verapamil Label ), HYDROXYUREA (500 Mg, Bid) (View Hydroxyurea Review and Hydroxyurea Label ). Patient was hospitalized.

6641896-2 | Nephrogenic Systemic Fibrosis
on Mar 08, 2010 Male patient from UNITED STATES , weighting 389.9 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging abdominal, nuclear magnetic resonance imaging brain, coagulopathy, blood testosterone decreased and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: nephrogenic systemic fibrosis. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ).

6641332-6 | Abdominal Pain Upper, Arteriosclerosis, Atelectasis, Bacteraemia, Cardiac Murmur, Cardiomyopathy, Cerebrovascular Accident, Cough, Decubitus Ulcer
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, arteriosclerosis, atelectasis, bacteraemia, cardiac murmur, cardiomyopathy (What is cardiomyopathy?), cerebrovascular accident, cough, decubitus ulcer on Mar 05, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 178.6 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Optimark dosage: Unk. During the same period patient was treated with GADOLINIUM (Unk, Single) (View Gadolinium Review and Gadolinium Label ), OMNISCAN (Unk, Single) (View Omniscan Review and Omniscan Label ), MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), LONITEN (2.5 Mg, Qd (am)) (View Loniten Review and Loniten Label ), LIPITOR (20 Mg, Qd (night)) (View Lipitor Review and Lipitor Label ), COUMADIN (3 Mg, Qd) (View Coumadin Review and Coumadin Label ).

6641316-8 | Ascites, Atrioventricular Block, Cardiac Failure, Cardiomyopathy, Cellulitis, Erythema, Facial Bones Fracture, Gouty Arthritis, Haemorrhage
Adverse event was reported on Mar 05, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 18 Ml, Single) was diagnosed with nuclear magnetic resonance imaging, pain (What is pain?) and. Location: UNITED STATES , weighting 195.0 lb, Patient had the following side effects: ascites, atrioventricular block, cardiac failure, cardiomyopathy (What is cardiomyopathy?), cellulitis (What is cellulitis?), erythema, facial bones fracture, gouty arthritis, haemorrhage. During the same period patient was treated with OMNISCAN (Unk,unk, Single) (View Omniscan Review and Omniscan Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), SYNTHROID (125 Ug, Qd) (View Synthroid Review and Synthroid Label ), LYRICA (75 Mg, Bid) (View Lyrica Review and Lyrica Label ), LORTAB (7.5 Mg, Bid, Prn) (View Lortab Review and Lortab Label ), ZAROXOLYN (2.5 Mg, Every Other Day) (View Zaroxolyn Review and Zaroxolyn Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ).

6641312-0 | Angina Unstable, Arteriovenous Fistula Site Complication, Diarrhoea, Dysphagia, Electrocardiogram Qt Shortened, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Abnormal, Haematemesis, Hyperlipidaemia
on Mar 05, 2010 Female patient from UNITED STATES , weighting 181.7 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: angina unstable, arteriovenous fistula site complication, diarrhoea, dysphagia, electrocardiogram qt shortened, electrocardiogram st segment depression, electrocardiogram t wave abnormal, haematemesis, hyperlipidaemia. Optimark dosage: 20 Ml, Single. During the same period patient was treated with PROHANCE (17 Ml, Single) (View Prohance Review and Prohance Label ), INSULIN (3 Units, Qd (am)) (View Insulin Review and Insulin Label ), CATAPRES /00171101/ (0.3 Mg, Bid) (View Catapres /00171101/ Review and Catapres /00171101/ Label ), NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ), ATACAND (32 Mg, Qd) (View Atacand Review and Atacand Label ), NEPHROCAPS (1 Tab, Qd) (View Nephrocaps Review and Nephrocaps Label ), RENAGEL /01459901/ (3200 Mg, With Each Meal) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), SYNTHROID (25 Ug, Qd) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6639095-3 | Arteriosclerosis Coronary Artery, Ascites, Breast Mass, Bundle Branch Block Left, Cardiac Failure Congestive, Clubbing, Eustachian Tube Dysfunction, Gastroenteritis, Goitre
on Mar 05, 2010 Female patient from UNITED STATES , weighting 152.0 lb, was diagnosed with angiogram, venogram, hypertension, dialysis (What is dialysis?) and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, ascites, breast mass, bundle branch block left, cardiac failure congestive, clubbing, eustachian tube dysfunction, gastroenteritis (What is gastroenteritis?), goitre. Optimark dosage: Unk. During the same period patient was treated with HYDRALAZINE HCL (100 Mg (2 Tablets), Tid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), IMDUR (30 Mg, Qd) (View Imdur Review and Imdur Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ), PHOSLO (667 Mg, Tid (1 Tablet With Meals)) (View Phoslo Review and Phoslo Label ), RENAGEL /01459901/ (1600 Mg, Tid) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), PREVACID (30 Mg, Qd (1 Tablet Before Breakfast)) (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6637102-5 | Arteriosclerosis Coronary Artery, Arthropathy, Atelectasis, Calculus Ureteric, Cholelithiasis, Conjunctivitis, Device Related Infection, Diverticulum Intestinal
Patient was taking Optimark (View Usage). Patient had the following side effects: arteriosclerosis coronary artery, arthropathy, atelectasis, calculus ureteric, cholelithiasis, conjunctivitis, device related infection, diverticulum intestinal on Mar 05, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and. Optimark dosage: Unk. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), TYLENOL (CAPLET) (1000 Mg, Every 6 Hrs Prn) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ZOFRAN (Every 6 Hrs Prn) (View Zofran Review and Zofran Label ), DARVOCET A500 (1 Tablet Every 4 Hrs Prn) (View Darvocet A500 Review and Darvocet A500 Label ), TUMS /00108001/ (500 Mg, 1 Tablet 30 Minutes Before Meals) (View Tums /00108001/ Review and Tums /00108001/ Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

Showing 1-50 of 156  Next Page  >


Share Your Experience, Join the Discussion:

Go to the top of the page

Optimark Questions, Answers, Feedback and Comments

No comments have been provided.

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Optimark risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Optimark quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Optimark use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

optimark Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: ortho Episodes: 9: Diagnosed with major depression.Side ...

optimark Episodes: 3: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: ortho Episodes: 4: Diagnosed with major depression.Side ...

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.

During the same period patient was treated with OPTIMARK (As Used: 20 Ml) (View Optimark Review and Optimark Label ), OMNISCAN (View Omniscan Review and Omniscan Label ), ...

optimark Episodes: 70: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: optiray Episodes: 9: Diagnosed with major depression.Side ...

optimark Episodes: 3: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: osmitrolection Episodes: 2: Diagnosed with major depression ...

optimark Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: pegasys Episodes: 1: Diagnosed with major depression.Side ...

optimark Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: protopic Episodes: 1: Diagnosed with major depression.Side ...

optimark Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: orencia Episodes: 1: Diagnosed with major depression.Side ...

onicit Episodes: 1: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: optimark Episodes: 4: Diagnosed with major depression.Side ...

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Optimark Reactions
Abdominal Distension
Abdominal Pain Upper
Activities Of Daily Living Impaired
Ammonia Increased
Anaemia
Angina Unstable
AnxietyWhat is Anxiety?
Ascites
Asthenia
Atrial FibrillationWhat is Atrial fibrillation?
Back PainWhat is Back pain?
Basal Cell Carcinoma
Cardiac Failure Congestive
Cardiac Murmur
Chest PainWhat is Chest pain?
Clavicle Fracture
Confusional State
Conjunctivitis
ConstipationWhat is Constipation?
Cough
Deep Vein ThrombosisWhat is Deep vein thrombosis?
DepressionWhat is Depression?
Diverticulum
DizzinessWhat is Dizziness?
FallWhat is Fall?
HeadacheWhat is Headache?
Injection Site Extravasation
Nephrogenic Systemic Fibrosis
Off Label Use
Post Procedural Complication
Optimark Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Optimark adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!